Sudair Pharma Recognized by the Local Content and Government Procurement Authority During Executive Visit
Sudair Pharma welcomed the CEO of the Local Content and Government Procurement Authority (LCGPA) in a visit during which the company was honored as a strategic national partner for its active role in strengthening local content and contributing to the national economy.
Sudair Pharma Signs MoU with AWS and SUDO Consultants to Advance Digital Transformation
Sudair Pharma signed a Memorandum of Understanding with AWS and SUDO Consultants to accelerate digital transformation and strengthen the company’s technological capabilities in the healthcare sector.
Sudair Pharma Participates in BIO 2025 to Advance Global Partnerships and Innovative Therapies
Sudair Pharma participated in BIO 2025, engaging with global biotech and pharmaceutical leaders to advance partnerships and expand access to innovative therapies across the Kingdom and MENA region.
Sudair Pharma Signs Strategic Agreements at GHE25 to Strengthen National Pharmaceutical Supply and Local Manufacturing
Sudair Pharma signed two major agreements during the Global Health Exhibition 2025: a cooperation agreement with NUPCO to enhance the national pharmaceutical supply chain, and a localization agreement with the Local Content & Government Procurement Authority to manufacture Bilotinib locally. These agreements reinforce Sudair Pharma’s commitment to national self-sufficiency and Vision 2030 goals in pharmaceutical manufacturing.